The way the announcement made no mention of the adult trial makes me think that the company’s sense is that this might become a full approval which is not conditional on the adult trial commencing, even though it will be happening anyway.. (Remember it won’t cost much because of the BNT-CTN involvement but if successful will vastly expand the market.)
Hope this is the first of many goals being kicked.
- Forums
- ASX - By Stock
- MSB
- Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA, page-85
-
-
- There are more pages in this discussion • 1,008 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
|
|||||
Last
$1.08 |
Change
-0.015(1.38%) |
Mkt cap ! $1.227B |
Open | High | Low | Value | Volume |
$1.10 | $1.10 | $1.06 | $3.054M | 2.852M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
33 | 140039 | $1.07 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.08 | 32101 | 17 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
34 | 141232 | 1.070 |
20 | 169281 | 1.065 |
25 | 209541 | 1.060 |
18 | 272481 | 1.055 |
23 | 164695 | 1.050 |
Price($) | Vol. | No. |
---|---|---|
1.075 | 25226 | 15 |
1.080 | 147659 | 20 |
1.085 | 98317 | 11 |
1.090 | 94635 | 12 |
1.095 | 66206 | 7 |
Last trade - 14.41pm 20/06/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |
The Watchlist
HAR
HARANGA RESOURCES LIMITED.
Peter Batten, MD
Peter Batten
MD
Previous Video
Next Video
SPONSORED BY The Market Online